In stepping away from the RWA, Elsevier acknowledged that it had made a strategic mistake. It clearly also made a serious PR gaffe. Whether the company has done lasting damage to its relationship with the research community remains uncertain, but the fact that researchers are continuing to sign up to the boycott Elsevier web site — created in protest at the publisher’s support for the bill — must clearly be a cause for concern.
What the RWA fiasco underlines is that while publishers are increasingly willing to embrace Gold OA (OA publishing), their antipathy towards Green OA (self-archiving) is growing, particularly where it is mandatory.
For that reason, Elsevier’s decision should be viewed as a political act alone, not a change of heart. Indeed, in announcing its withdrawal the publisher stressed that it remains firmly opposed to OA mandates.
Moreover, while OA advocates maintain that most publishers are now comfortable with the NIH policy this is surely only wish fulfilment. A week after the RWA died, after all, 81 publishers signed a letter opposing the Federal Research Public Access Act (FRPAA).
Introduced into both the US Senate and the House of Representatives on 9th February, far from outlawing the NIH policy, the FRPAA would propagate it — to around a dozen other US federal agencies. It would also reduce the embargo period from 12 months to six. As such, the bill would be a huge fillip for Green OA — although with the US elections approaching it seems highly unlikely to succeed, in the near future at least.
In short, the battle for OA goes on, but looks set to be fought primarily over Green OA henceforward.
Down under
Recent events on the other side of the globe would appear to confirm this. They also demonstrate that while the OA movement was victorious in the battle over the RWA, the war itself is far from over.
In a development generally under-reported outside Australia (pushed aside by the hubbub over the RWA perhaps), on 21st February the Australian National Health and Medical Research Council (NHMRC) announced that it plans to introduce an NIH-style mandate — effective July 1st.